Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02443519 · ClinicalTrials.gov registry record · NA
Bronx MBCT-Migraine
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02443519 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 60 participants.
The verdict
NCT02443519, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This randomized clinical trial aims to examine the effect of a standardized 8-week course of Mindfulness Based Cognitive Therapy for Migraine on migraine-related disability in people with migraine.
Interventions
- BEHAVIORAL MBCT for Migraine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02443519
The ClinicalTrials.gov registry entry for NCT02443519 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MBCT for Migraine is the first listed.
NCT02443519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02443519 about?
NCT02443519 is a clinical study titled "Bronx MBCT-Migraine". This randomized clinical trial aims to examine the effect of a standardized 8-week course of Mindfulness Based Cognitive Therapy for Migraine on migraine-related disability in people with migraine.
What is the current status of trial NCT02443519?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-07. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02443519?
The interventions under investigation include: MBCT for Migraine (BEHAVIORAL).
Who is sponsoring clinical trial NCT02443519?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.